- Home
- RPID vs LUCD Comparison
RPID vs LUCD Comparison
Compare RPID & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- LUCD
- Stock Information
- Founded
- RPID 2006
- LUCD 2018
- Country
- RPID United States
- LUCD United States
- Employees
- RPID N/A
- LUCD N/A
- Industry
- RPID Medical Specialities
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RPID Health Care
- LUCD Health Care
- Exchange
- RPID Nasdaq
- LUCD Nasdaq
- Market Cap
- RPID 106.5M
- LUCD 105.0M
- IPO Year
- RPID 2021
- LUCD 2021
- Fundamental
- Price
- RPID $3.03
- LUCD $1.03
- Analyst Decision
- RPID Strong Buy
- LUCD Strong Buy
- Analyst Count
- RPID 2
- LUCD 5
- Target Price
- RPID $8.00
- LUCD $3.65
- AVG Volume (30 Days)
- RPID 64.5K
- LUCD 1.5M
- Earning Date
- RPID 10-31-2025
- LUCD 11-12-2025
- Dividend Yield
- RPID N/A
- LUCD N/A
- EPS Growth
- RPID N/A
- LUCD N/A
- EPS
- RPID N/A
- LUCD N/A
- Revenue
- RPID $30,289,000.00
- LUCD $4,360,000.00
- Revenue This Year
- RPID $16.63
- LUCD $22.80
- Revenue Next Year
- RPID $21.98
- LUCD $221.19
- P/E Ratio
- RPID N/A
- LUCD N/A
- Revenue Growth
- RPID 22.57
- LUCD 14.74
- 52 Week Low
- RPID $0.80
- LUCD $0.73
- 52 Week High
- RPID $4.50
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- RPID 55.88
- LUCD 42.51
- Support Level
- RPID $2.63
- LUCD $1.01
- Resistance Level
- RPID $3.11
- LUCD $1.54
- Average True Range (ATR)
- RPID 0.19
- LUCD 0.10
- MACD
- RPID 0.09
- LUCD -0.02
- Stochastic Oscillator
- RPID 89.63
- LUCD 3.77
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.